News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Mesoblast Limited Disc Repair Results Highlighted At Key Orthopaedic Conference
September 15, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Melbourne, Sep 15, 2009 (ABN Newswire) - Mesoblast Limited's (ASX:MSB)(PINK:MBLTY) successful preclinical disc repair trial was featured at the World Congress on Osteoarthritis held in Montreal, Canada, over the weekend.
Twitter
LinkedIn
Facebook
Email
Print
Events
Preclinical
Australia
MORE ON THIS TOPIC
Cardiovascular disease
Gossamer Nosedives as Late-Stage Failure Plunges PAH Program Into Uncertainty
February 24, 2026
·
2 min read
·
Tristan Manalac
Weight loss
Novo’s CagriSema Falls to Lilly’s Zepbound in Daring Head-to-Head Test
February 23, 2026
·
4 min read
·
Annalee Armstrong
Insights
Historic ALS Investment Signals New Treatment Momentum
February 23, 2026
·
3 min read
·
Jennifer Smith-Parker
MASH
Beyond Rezdiffra: The 4 Most Promising MASH Pipelines in Play
February 23, 2026
·
6 min read
·
Ben Hargreaves